Publicacións nas que colabora con Valentina Calamia . (50)

2024

  1. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining

    Molecular and Cellular Proteomics, Vol. 22, Núm. 8

2022

  1. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

2021

  1. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

    Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

  2. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  3. Targeted phospholipidomic analysis of synovial fluid as a tool for osteoarthritis deep phenotyping

    Osteoarthritis and Cartilage Open, Vol. 3, Núm. 4

2020

  1. Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 574-588

2019

  1. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

    Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

  2. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis

    Therapeutic Advances in Chronic Disease, Vol. 10

2018

  1. In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis

    International Immunopharmacology, Vol. 64, pp. 86-100

2017

  1. Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

    Journal of Proteomics, Vol. 152, pp. 216-225

2016

  1. Identification of factors produced and secreted by mesenchymal stromal cells with the SILAC method

    Methods in Molecular Biology (Humana Press Inc.), pp. 551-565

  2. Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint

    Proteomics - Clinical Applications, Vol. 10, Núm. 6, pp. 671-680

2015

  1. Lessons from the proteomic study of osteoarthritis

    Expert Review of Proteomics, Vol. 12, Núm. 4, pp. 433-443

  2. The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases

    Journal of Proteomics, Vol. 127, pp. 406-413

2014

  1. A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine

    Scientific Reports, Vol. 4

  2. Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis

    Journal of Proteome Research, Vol. 13, Núm. 12, pp. 6096-6106

  3. Secretome analysis of human mesenchymal stem cells undergoing chondrogenic differentiation

    Journal of Proteome Research, Vol. 13, Núm. 2, pp. 1045-1054

2013

  1. A new fast method for peptide biomarker discovery in human serum by mass spectrometry

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 52-52